United States v. McElwee

646 F.3d 328, 2011 WL 2686447
CourtCourt of Appeals for the Fifth Circuit
DecidedJuly 12, 2011
Docket10-30099, 10-30101
StatusPublished
Cited by177 cases

This text of 646 F.3d 328 (United States v. McElwee) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. McElwee, 646 F.3d 328, 2011 WL 2686447 (5th Cir. 2011).

Opinion

E. GRADY JOLLY, Circuit Judge:

Before the court are three former employees of a private medical practice who stand convicted for engaging in a conspiracy to fraudulently obtain large amounts of hydrocodone, a controlled dangerous substance. The conspiracy involved submission of fabricated prescriptions to local pharmacies and falsification of patient medical records to conceal the fraudulence of the prescriptions. Appellants were found guilty of various charges, including *335 conspiracy to obtain a controlled substance by fraud, and were sentenced to respective terms of imprisonment. All three Appellants challenge their sentences, and one Appellant contests the grounds for her conviction as well. For the reasons that follow, we AFFIRM on all issues.

I.

Appellant Tandy McElwee (“Dr. McElwee”) was an OB/GYN physician who maintained a practice in Bossier City, Louisiana. There he supervised 13 employees including his wife, Appellant Ava McElwee (“Mrs. McElwee”), a nurse practitioner, and Appellant Wendy Chriss (“Chriss”), a registered medical assistant. Dr. McElwee was authorized by the U.S. Drug Enforcement Administration (“DEA”) to prescribe lawful controlled substances, but he did not have a license to dispense controlled substances from the State of Louisiana.

Over a period of years, employees of the medical practice employed a variety of fraudulent means to obtain hydrocodone medications including Lorcet, Lortab, Histussin HC, and Histinex HC, all of which are schedule III controlled dangerous substances. To effectuate this conspiracy, Dr. McElwee made available to his employees pre-signed prescription pads, which were used to request refills of these hydrocodone-containing drugs from various pharmacies. Trial testimony suggested that the atmosphere in Dr. McElwee’s office was one that accepted and accommodated the daily use of hydrocodone.

The coconspirators were able to obtain large amounts of hydrocodone medication by submitting pre-signed “prescriptions” in the names of fictitious persons, other family members, and in one case, even a family dog. For example, Chriss ordered hydrocodone using names like Kathleen Benson (her middle and maiden name), Eddie Chriss (her husband), Ayden Chriss (her child), Kristina Randall (her sister), and Rochelle Petouski (an alias for her sister). Dr. McElwee secured hydrocodone for himself and others by having his medical assistant, Rebecca Sandifer, go to the pharmacy to pick up prescriptions in the names of Sandifer’s children and her ex-husband. He also ordered prescriptions using the name of his dog “Brandi” and his daughter-in-law, Conchita McElwee. When questioned by a pharmacist, Dr. McElwee represented that “Brandi McElwee” was a patient under his care.

Dr. McElwee authorized Chriss to order hydrocodone via the Internet from Moore Medical, LLC, and he testified that he kept a large 500-count bottle in his office for personal use and gave another 500-count bottle to Chriss for use by office personnel or their family members. Although Mrs. McElwee’s level of involvement in these schemes was disputed, many prescriptions — including for Lortab and Histussin HC — were filled out in her name, and she often retrieved the medications from the pharmacy. Another employee testified that she delivered prescriptions to Mrs. McElwee, and the jury apparently credited the trial testimony suggesting that Mrs. McElwee knew of and participated in the conspiracy.

Dr. McElwee’s staff frequently submitted prescriptions to QVL Pharmacy (which was originally named “Safescript”). In June 2007, the Louisiana State Board of Medical Examiners (“LSBME”) issued subpoenas to QVL and to Dr. McElwee’s office for approximately 22 patient records, including requests for the patient records of Dr. McElwee’s staff and for the family members and fictitious “patients” under whose names the prescriptions had been filled. An employee of QVL notified Chriss about the LSBME subpoenas and sent Chriss a fax containing the details of *336 prescriptions QVL had filled for Dr. McElwee’s office. Based on these records from the pharmacy, Chriss and other employees altered and falsified patient records to account for the prescriptions filled by QVL. Certain patient charts were fabricated wholesale, including those of “Rochelle Petouski” and “Missy Davis.” Furthermore, the record indicates that Mrs. McElwee participated in the falsification of patient records, specifically with respect to Conchita “Brandi” McElwee (the family dog’s name apparently having been added to the chart for Dr. McElwee’s daughter-in-law). 1 These falsified records were submitted in response to the LSBME subpoena. In addition, Chriss created a dispensation log book with false names and prescription dates, at Dr. McElwee’s request, in order to account for the hydrocodone ordered through Moore Medical. Another employee testified that Mrs. McElwee said Chriss was “going to save our ass with that book.”

Appellants were indicted along with five other codefendants in an 88-count indictment that included charges for conspiracy to obtain a controlled substance by fraud and conspiracy to possess with intent to distribute a controlled substance. Under a plea agreement, Chriss pleaded guilty to one count of conspiracy to possess with intent to distribute a controlled substance, in violation of 21 U.S.C. §§ 846 and 841(a)(1). A jury found Dr. McElwee guilty of one count of conspiracy to obtain a controlled substance by fraud, in violation of 21 U.S.C. §§ 846 and 843(a)(3); nineteen counts of obtaining a controlled substance by fraud, in violation of 21 U.S.C. § 843(a)(3) and 18 U.S.C. § 2; one count of conspiracy to possess with intent to distribute; nine counts of possession with intent to distribute a controlled dangerous substance, in violation of 21 U.S.C. § 841(a)(1) and 18 U.S.C. § 2; one count of providing false information in records required to be kept under Title 21, in violation of 21 U.S.C. § 843(a)(4)(A) and 18 U.S.C. § 2; and one count of health care fraud, in violation of 18 U.S.C. §§ 1347 and 2. The same jury found Mrs. McElwee guilty of one count of conspiracy to obtain a controlled substance by fraud and one count of obtaining or acquiring a controlled substance by fraud.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Luna
Fifth Circuit, 2023
United States v. Cortez-Balderas
74 F.4th 786 (Fifth Circuit, 2023)
United States v. Hudgens
4 F.4th 352 (Fifth Circuit, 2021)
United States v. Rene Colon
Fifth Circuit, 2018
United States v. Gabriel Rivera-Gonzalez
623 F. App'x 201 (Fifth Circuit, 2015)
United States v. Mickey Perez
618 F. App'x 241 (Fifth Circuit, 2015)
United States v. Benedicto Lazaro-Lopez
619 F. App'x 374 (Fifth Circuit, 2015)
United States v. Santiago Diaz-Hernandez
615 F. App'x 176 (Fifth Circuit, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
646 F.3d 328, 2011 WL 2686447, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-mcelwee-ca5-2011.